trial
as of 2026-07-01Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
NCTId NCT04892199
at a glance
Phase 4 · Active Not Recruiting
Enrollment 104 (estimated)
Sponsored by Anders Fink-Jensen, MD, DMSci
Primary completion 2026-03-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Active Not Recruiting
Enrollment
104 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2021-09-01
Primary completion
2026-03-01
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Anders Fink-Jensen, MD, DMSciLead Sponsor
Investigators
1
Anders Fink-Jensen, MDPrincipal Investigator
Sites
3 total
Aarhus, DenmarkCopenhagen, DenmarkHillerød, Denmark
Facts & assertions
4 sourced
Enrollment
104
Phase
PHASE4
Primary Completion Date
2026-03-01
Status
ACTIVE_NOT_RECRUITING
relationships
The graph out of here
drug
lead_sponsor
indication
investigator
person